CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- S-3ASR Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale Principal Accounting Officer sold 233 shares at $27.21 ($6,340)
- 4 Open-market sale Principal Accounting Officer sold 504 shares at $28.59 ($14,409)
- 4 Shares withheld for taxes Chief Legal Officer gave up 609 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 3,648 shares (to pay taxes)
- 4 Open-market sale Director sold 20,000 shares at $28.62 ($572,400)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes Chief Legal Officer gave up 643 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 758 shares (to pay taxes)
- 4 Shares withheld for taxes Principal Accounting Officer gave up 273 shares (to pay taxes)
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale Director sold 20,000 shares at an average $29.33 ($586,578)
Page 18 of 66 · 1,304 filings